Batavia Biosciences Expands Viral Vector Facilities

By Akia Thorpe -

October 17, 2017

Batavia Biosciences, a contract biologics manufacturer based in Leiden, the Netherlands, has expanded its viral vector process development facilities in the US and its GMP cleanroom facilities in the Netherlands.

The research and development (R&D) facility in Medford, Massachusetts allows Batavia Biosciences to add preclinical process development capabilities for viral vectors, including adeno-associated virus, lentivirus, vesicular stomatitis virus, and adenovirus systems to its portfolio of Chinese hamster ovary cell-line generation and process development services for recombinant proteins and antibodies.

The expansion of the company’s GMP cleanroom facilities in Leiden, combined with its increased R&D capability, is intended to support the manufacturing of master cell banks and vaccine seed stocks.

Source: Batavia Biosciences